Historical research on reduction of childhood mortality due to vaccination To what extent has the National Vaccination Programme contributed to the prevention of disease and mortality since the beginning of the 20th century?
Need for adjustment authorisation for gene drive applications The National Institute for Public Health and the Environment (RIVM) advises to bring all gene drive applications under the authorisation requirement of the Dutch GMO legislation.
Nanotechnology in the fight against cancer Nanotechnology offers improved options for the diagnosis and treatment of cancer.
Tracking down sources of disease outbreaks like Sherlock Holmes. 'I want to know the story behind an epidemic'. Interview with Jaap van Dissel, Director of RIVM Centre for Infectious Disease Control.
Cervical cancer screening in the Netherlands January 19 - 25 European Cervical Cancer Prevention Week.
State of infectious diseases in The Netherlands RIVM report 'State of Infectious Diseases 2012' provides insight into the development of infectious diseases in The Netherlands.
ICP M&M meetings in 2013 The 23rd CCE Workshop and 29th Task Force Meeting of the ICP M&M will be held 8-11 April 2013 in Copenhagen, Denmark.
Call for data on "no net loss of biodiversity" The CCE is pleased to publicate an announcement and a detailed substantiation and technical description of the call for data on “no net loss of biodiversity” which has been adopted at the 31st meet
End to Marburg risk On 11 July 2008, a Dutch woman died of Marburg haemorrhagic fever, a serious illness caused by the Marburg virus, which she had contracted in Uganda during a visit to a bat cave.